Progenitor Hematopoietic Cells Implantation Improves Functional Capacity of End Stage Coronary Artery Disease Patients with Advanced Heart Failure

<div>After 5 days of culture in the presence of VEGF and statin, the cells were stained with DAPI (a), UEA-1 lectin (b), Dil-acetylated LDL (c), and merge image (d). The cells exhibit the ability to bind lectin and uptake ac-LDL, one of the characteristics of eEPCs. Original magnification ×100.</div>

Cardiology Research and Practice

fig3

Figure 3

Figure 3: Progenitor Hematopoietic Cells Implantation Improves Functional Capacity of End Stage Coronary Artery Disease Patients with Advanced Heart Failure 

Figure 3 | Progenitor Hematopoietic Cells Implantation Improves Functional Capacity of End Stage Coronary Artery Disease Patients with Advanced Heart Failure 